155 related articles for article (PubMed ID: 15165174)
21. Application of proteomic technologies for prostate cancer detection, prognosis, and tailored therapy.
Fredolini C; Liotta LA; Petricoin EF
Crit Rev Clin Lab Sci; 2010; 47(3):125-38. PubMed ID: 20858067
[TBL] [Abstract][Full Text] [Related]
22. Proteomic strategies in bladder cancer.
Celis JE; Wolf H; Ostergaard M
IUBMB Life; 1999 Jul; 48(1):19-23. PubMed ID: 10791911
[TBL] [Abstract][Full Text] [Related]
23. [Application of proteomics to diagnosis and treatment of lung cancer].
Dai M; Luo RC
Ai Zheng; 2007 Jun; 26(6):669-72. PubMed ID: 17562279
[TBL] [Abstract][Full Text] [Related]
24. Urinary bladder tumor markers.
Lokeshwar VB; Selzer MG
Urol Oncol; 2006; 24(6):528-37. PubMed ID: 17138134
[TBL] [Abstract][Full Text] [Related]
25. Strategies to improve drug delivery in bladder cancer therapy.
Wirth M; Plattner VE; Gabor F
Expert Opin Drug Deliv; 2009 Jul; 6(7):727-44. PubMed ID: 19538035
[TBL] [Abstract][Full Text] [Related]
26. Proteomic approaches to the discovery of cancer biomarkers for early detection and personalized medicine.
Honda K; Ono M; Shitashige M; Masuda M; Kamita M; Miura N; Yamada T
Jpn J Clin Oncol; 2013 Feb; 43(2):103-9. PubMed ID: 23248327
[TBL] [Abstract][Full Text] [Related]
27. Approaching clinical proteomics: current state and future fields of application in cellular proteomics.
Apweiler R; Aslanidis C; Deufel T; Gerstner A; Hansen J; Hochstrasser D; Kellner R; Kubicek M; Lottspeich F; Maser E; Mewes HW; Meyer HE; Müllner S; Mutter W; Neumaier M; Nollau P; Nothwang HG; Ponten F; Radbruch A; Reinert K; Rothe G; Stockinger H; Tárnok A; Taussig MJ; Thiel A; Thiery J; Ueffing M; Valet G; Vandekerckhove J; Wagener C; Wagner O; Schmitz G
Cytometry A; 2009 Oct; 75(10):816-32. PubMed ID: 19739086
[TBL] [Abstract][Full Text] [Related]
28. Identification of anti-infective targets through comparative proteomics.
Burchmore R
Expert Rev Anti Infect Ther; 2006 Apr; 4(2):163-5. PubMed ID: 16597196
[No Abstract] [Full Text] [Related]
29. Oncoproteomics.
Joshi S; Tiwari AK; Mondal B; Sharma A
Clin Chim Acta; 2011 Jan; 412(3-4):217-26. PubMed ID: 20955692
[TBL] [Abstract][Full Text] [Related]
30. Proteomics makes progress in cartilage and arthritis research.
Wilson R; Whitelock JM; Bateman JF
Matrix Biol; 2009 Apr; 28(3):121-8. PubMed ID: 19379666
[TBL] [Abstract][Full Text] [Related]
31. Intravesical delivery of small activating RNA formulated into lipid nanoparticles inhibits orthotopic bladder tumor growth.
Kang MR; Yang G; Place RF; Charisse K; Epstein-Barash H; Manoharan M; Li LC
Cancer Res; 2012 Oct; 72(19):5069-79. PubMed ID: 22869584
[TBL] [Abstract][Full Text] [Related]
32. Moving forward in bladder cancer detection and diagnosis: the role of epigenetic biomarkers.
Oliveira AI; Jerónimo C; Henrique R
Expert Rev Mol Diagn; 2012 Nov; 12(8):871-8. PubMed ID: 23249204
[TBL] [Abstract][Full Text] [Related]
33. Proteomic assays for the detection of urothelial cancer.
Gaston KE; Grossman HB
Methods Mol Biol; 2010; 641():303-23. PubMed ID: 20407954
[TBL] [Abstract][Full Text] [Related]
34. How will haematologists use proteomics?
Unwin RD; Whetton AD
Blood Rev; 2007 Nov; 21(6):315-26. PubMed ID: 17889973
[TBL] [Abstract][Full Text] [Related]
35. High throughput genomic and proteomic technologies in the fight against infectious diseases.
Tanca A; Deligios M; Addis MF; Uzzau S
J Infect Dev Ctries; 2013 Mar; 7(3):182-90. PubMed ID: 23492995
[TBL] [Abstract][Full Text] [Related]
36. Molecular genetics of bladder cancer: targets for diagnosis and therapy.
Baffa R; Letko J; McClung C; LeNoir J; Vecchione A; Gomella LG
J Exp Clin Cancer Res; 2006 Jun; 25(2):145-60. PubMed ID: 16918124
[TBL] [Abstract][Full Text] [Related]
37. Proteomics: addressing the challenges of osteoarthritis.
De Ceuninck F; Berenbaum F
Drug Discov Today; 2009 Jul; 14(13-14):661-7. PubMed ID: 19477289
[TBL] [Abstract][Full Text] [Related]
38. Mass spectrometry-based proteomics: the road to lung cancer biomarker discovery.
Indovina P; Marcelli E; Pentimalli F; Tanganelli P; Tarro G; Giordano A
Mass Spectrom Rev; 2013; 32(2):129-42. PubMed ID: 22829143
[TBL] [Abstract][Full Text] [Related]
39. The birth and infancy of proteomic analysis in osteoarthritis research.
De Ceuninck F
Curr Opin Mol Ther; 2007 Jun; 9(3):263-9. PubMed ID: 17608025
[TBL] [Abstract][Full Text] [Related]
40. Structural proteomics by NMR spectroscopy.
Shin J; Lee W; Lee W
Expert Rev Proteomics; 2008 Aug; 5(4):589-601. PubMed ID: 18761469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
